Succinyl Curcumin Conjugated Chitosan Polymer-Prodrug Nanomicelles: A Potential Treatment for Type-II Diabetes in Diabetic Balb/C Mice.
Acta Chim Slov
; 71(2): 421-435, 2024 Jun 10.
Article
en En
| MEDLINE
| ID: mdl-38919100
ABSTRACT
Diabetes mellitus is a chronic metabolic disorder marked by elevated blood sugar levels, leading to organ dysfunction. Curcumin, derived from turmeric, exhibits promise in managing type II diabetes. Nanomicelles were created by conjugating curcumin with chitosan through succinic anhydride. Succinyl-curcumin, the resultant compound, was esterified with chitosan to form a polymer prodrug conjugate. Nanomicelles, formed via dialysis, were spherical with a hydrodynamic size of 49.37 nm. In vitro release studies revealed 97% curcumin release at pH 5 in 7 days. A 21-day experiment on diabetic mice compared nanomicelles, standard drug, and free curcumin's impact on fasting blood glucose. The study showcased gradual, controlled curcumin release from nanomicelles, suggesting their potential in type II diabetes treatment.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Profármacos
/
Curcumina
/
Quitosano
/
Diabetes Mellitus Experimental
/
Diabetes Mellitus Tipo 2
/
Ratones Endogámicos BALB C
/
Micelas
Límite:
Animals
Idioma:
En
Revista:
Acta Chim Slov
Año:
2024
Tipo del documento:
Article
País de afiliación:
India
Pais de publicación:
Eslovenia